MannKind Corp. (MNKD)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about MannKind Corp. (MNKD)
Go deeper and ask any question about MNKD
Company Performance
Current Price
as of Sep 13, 2024$6.27
P/E Ratio
173.68
Market Cap
$1.72B
Description
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Metrics
Overview
- HQDanbury, CT
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerMNKD
- Price$6.27+1.13%
Trading Information
- Market Cap$1.72B
- Float96.88%
- Average Daily Volume (1m)2,975,887
- Average Daily Volume (3m)2,720,677
- EPS$0.04
Company
- Revenue$248.37M
- Rev Growth (1yr)48.91%
- Net Income-$2.01M
- Gross Margin71.85%
- EBITDA Margin25.02%
- EBITDA$18.11M
- EV$1.52B
- EV/Revenue6.10
- P/E173.68
- P/S6.89
Documents
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia